Advanced Flower Capital (AFCG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Board unanimously approved a plan to convert from a REIT to a BDC, aiming for greater investment flexibility and alignment with long-term strategy.
Conversion will involve revoking REIT status, electing BDC regulation, and seeking RIC tax treatment as soon as practicable.
Special Meeting scheduled for November 6, 2025, for shareholders to vote on key proposals required for the conversion.
Conversion expected to occur in the first quarter of 2026, pending shareholder approval.
Board believes BDC structure will enhance portfolio diversification, investment flexibility, and transparency.
Voting matters and shareholder proposals
Shareholders are asked to approve a new 1940 Act-compliant investment advisory agreement with AFC Management, LLC.
Approval sought for reduced asset coverage requirements, lowering from 200% to 150%, allowing increased leverage.
Board recommends voting FOR both proposals; approval of Proposal 1 is required for the conversion to proceed.
Shareholders of record as of September 15, 2025, are eligible to vote; quorum is a majority of shares present or by proxy.
Voting can be done online, by phone, mail, or during the virtual meeting.
Board of directors and corporate governance
Board and independent directors reviewed and approved the new advisory agreement after considering service quality, fees, profitability, and alignment with shareholder interests.
Key executives include Leonard M. Tannenbaum (Chairman), Robyn Tannenbaum (President & CIO), and Daniel Neville (CEO).
Directors and executive officers collectively own approximately 25.1% of outstanding shares.
Board considered peer BDC fee structures and determined proposed fees are fair and not unreasonable.
Latest events from Advanced Flower Capital
- Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCG
Q2 202510 Mar 2026 - BDC conversion expanded investment scope; $31.3M interest income, $0.05 dividend declared.AFCG
Q4 20254 Mar 2026 - Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCG
Q2 20242 Feb 2026 - Q3 2024 earnings met targets, with strong originations and higher risk post-CRE spin-off.AFCG
Q3 202414 Jan 2026 - Exceeded origination targets, delivered strong yields, and maintained a robust pipeline.AFCG
Q4 202424 Dec 2025 - REIT lender to cannabis sector files $1B shelf registration for flexible equity and debt offerings.AFCG
Registration Filing16 Dec 2025 - Shareholders will vote on director election and auditor ratification, with Board support.AFCG
Proxy Filing2 Dec 2025 - Shareholders to vote on REIT-to-BDC conversion and new advisory agreement for expanded flexibility.AFCG
Proxy Filing2 Dec 2025 - Vote on director election and auditor ratification at the May 2025 virtual annual meeting.AFCG
Proxy Filing2 Dec 2025